Published in Blood on October 15, 1998
An overview of the serpin superfamily. Genome Biol (2006) 2.14
The N terminus of the serpin, tengpin, functions to trap the metastable native state. EMBO Rep (2007) 0.97
Allosteric modulation of hormone release from thyroxine and corticosteroid-binding globulins. J Biol Chem (2011) 0.87
Temperature-responsive release of thyroxine and its environmental adaptation in Australians. Proc Biol Sci (2014) 0.80
The infective polymerization of conformationally unstable antithrombin mutants may play a role in the clinical severity of antithrombin deficiency. Mol Med (2012) 0.80
Amyloid associated with elastin-staining laminar aggregates in the lungs of patients diagnosed with acute respiratory distress syndrome. BMC Pulm Med (2002) 0.79
The role of strand 1 of the C beta-sheet in the structure and function of alpha(1)-antitrypsin. Protein Sci (2001) 0.78
Analysis of surface cavity in serpin family reveals potential binding sites for chemical chaperone to reduce polymerization. J Mol Model (2011) 0.76
A small deletion in SERPINC1 causes type I antithrombin deficiency by promoting endoplasmic reticulum stress. Oncotarget (2016) 0.75
Hydration effects of heparin on antithrombin probed by osmotic stress. Biophys J (2002) 0.75
Heparin Binds Lamprey Angiotensinogen and Promotes Thrombin Inhibition through a Template Mechanism. J Biol Chem (2016) 0.75
Multiple Retinal Vein Occlusions Associated with Anti-thrombin III Deficiency. J Ophthalmic Vis Res (2016) 0.75
Conformational preludes to the latency transition in PAI-1 as determined by atomistic computer simulations and hydrogen/deuterium-exchange mass spectrometry. Sci Rep (2017) 0.75
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst (1998) 22.10
The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet (2000) 15.19
Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A (1998) 13.39
Antenatal maternal serum screening for Down's syndrome: results of a demonstration project. BMJ (1992) 9.08
Duplication of CaMV 35S Promoter Sequences Creates a Strong Enhancer for Plant Genes. Science (1987) 6.00
The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature (1992) 5.71
The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping. Cell (1994) 5.21
The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem (2001) 4.81
Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA (1997) 4.79
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost (2006) 4.58
Structure and variation of human alpha 1-antitrypsin. Nature (1982) 4.13
Structure of a serpin-protease complex shows inhibition by deformation. Nature (2000) 4.02
Identification of bile duct stones in patients undergoing laparoscopic cholecystectomy. Br J Surg (1991) 3.65
Factor VIII gene rearrangements in patients with severe haemophilia A. Lancet (1994) 3.56
Life expectancy, economic inequality, homicide, and reproductive timing in Chicago neighbourhoods. BMJ (1997) 3.56
Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function. Genome Res (2000) 3.55
Identity of viridans streptococci isolated from cases of infective endocarditis. J Med Microbiol (1993) 3.36
Increased fetal loss in women with heritable thrombophilia. Lancet (1996) 3.34
Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins. Biochemistry (1989) 3.18
The anticoagulant activation of antithrombin by heparin. Proc Natl Acad Sci U S A (1997) 3.09
Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med (1996) 3.07
The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry (2006) 2.80
The estimation of red cell superoxide dismutase activity. J Lab Clin Med (1975) 2.75
BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet (1996) 2.75
A structural explanation for the binding of multiple ligands by the alpha-adaptin appendage domain. Cell (1999) 2.65
Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol (1994) 2.52
Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat Genet (1996) 2.48
Size Inheritance and Geometric Growth Processes in the Tomato Fruit. Genetics (1938) 2.46
Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst (1995) 2.45
Hepatitis C antibody and chronic liver disease in haemophilia. Lancet (1990) 2.44
Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. Proc Natl Acad Sci U S A (1997) 2.42
Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. Lancet (1999) 2.36
Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder. N Engl J Med (1983) 2.36
Cerebral intravascular coagulation in diabetic ketoacidosis. Lancet (1974) 2.35
Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes. J Natl Cancer Inst (1998) 2.33
Engineering secondary metabolism in maize cells by ectopic expression of transcription factors. Plant Cell (1998) 2.31
What do dysfunctional serpins tell us about molecular mobility and disease? Nat Struct Biol (1995) 2.30
A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J (1993) 2.28
Acute encephalopathy coincident with seroconversion for anti-HTLV-III. Lancet (1985) 2.26
Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors Organisation. Thromb Haemost (1998) 2.20
The association of Angelman's syndrome with deletions within 15q11-13. J Med Genet (1989) 2.19
Essential thrombocythaemia and peripheral gangrene. Br Med J (1974) 2.18
Anti Xa monitoring during treatment with low molecular weight heparin or danaparoid: inter-assay variability. Thromb Haemost (1999) 2.15
Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). J Thromb Haemost (2005) 2.13
Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst (1993) 2.07
Variations in the structure of human haemoglobin. With particular reference to the unstable haemoglobins. Br Med Bull (1969) 2.07
Rare mutations in XRCC2 increase the risk of breast cancer. Am J Hum Genet (2012) 2.06
Risk reduction strategies for variant Creutzfeldt-Jakob disease transmission by UK plasma products and their impact on patients with inherited bleeding disorders. Haemophilia (2010) 2.03
Recurrent miscarriage: aetiology, management and prognosis. Hum Reprod Update (2002) 2.00
Smoking, lung function, and alpha 1-antitrypsin deficiency. Lancet (1985) 1.99
Molecular cloning and structural characterization of the Arg-gingipain proteinase of Porphyromonas gingivalis. Biosynthesis as a proteinase-adhesin polyprotein. J Biol Chem (1995) 1.98
Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia. Br J Haematol (2001) 1.94
Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland. Am J Hum Genet (2000) 1.93
Familial dementia caused by polymerization of mutant neuroserpin. Nature (1999) 1.88
Comparison of the reflex responses elicited by stimulation of the separately perfused carotid and aortic body chemoreceptors in the dog. J Physiol (1966) 1.87
A simple method for the detection of unstable haemoglobins. Br J Haematol (1972) 1.87
Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Am J Hum Genet (1995) 1.85
Activation of p38 mitogen-activated protein kinase and c-Jun NH(2)-terminal kinase by double-stranded RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways. Mol Cell Biol (2000) 1.83
Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy. Infect Immun (2001) 1.82
Kin discrimination by worker honey bees in genetically mixed groups. Proc Natl Acad Sci U S A (1985) 1.81
Lower-than-expected linkage disequilibrium between tightly linked markers in humans suggests a role for gene conversion. Am J Hum Genet (2001) 1.80
Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity. Blood (2001) 1.77
The natural history of chronic hepatitis C in haemophiliacs. Br J Haematol (1996) 1.76
Carrier detection by direct gene analysis in a family with haemophilia B (factor IX deficiency). Lancet (1984) 1.74
Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost (1998) 1.71
Exceptional familial clustering for extreme longevity in humans. J Am Geriatr Soc (2000) 1.69
Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates. Lancet (1990) 1.69
Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. Br J Cancer (1997) 1.69
Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease. Lancet (1980) 1.68
Intrinsic molecular activities of the interferon-induced 2-5A-dependent RNase. J Biol Chem (1994) 1.67
Thromboplastin related differences in the determination of international normalised ratio: a cause for concern? Steering Committee of the UK National External Quality Assessment Scheme in Blood Coagulation. Thromb Haemost (1994) 1.67
Reactions involving superoxide and normal and unstable haemoglobins. Biochem J (1976) 1.66
Inhibitory conformation of the reactive loop of alpha 1-antitrypsin. Nat Struct Biol (1996) 1.66
Organization of NMDA receptors at extrasynaptic locations. Neuroscience (2010) 1.66
A survey of hymenopteran parasitoids of forest macrolepidoptera in the central Appalachians. J Econ Entomol (2004) 1.65
Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies. Br J Haematol (1990) 1.64
Stomatocytic haemolysis and macrothrombocytopenia (Mediterranean stomatocytosis/macrothrombocytopenia) is the haematological presentation of phytosterolaemia. Br J Haematol (2005) 1.63
Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy. J Thromb Haemost (2010) 1.62
alpha 1-Antitrypsin: molecular pathology, leukocytes, and tissue damage. J Clin Invest (1986) 1.61
Heteropolymerization of S, I, and Z alpha1-antitrypsin and liver cirrhosis. J Clin Invest (1999) 1.60
Thrombocytosis, circulating platelet aggregates, and neurological dysfunction. Br Med J (1979) 1.59
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood (1995) 1.59
Topography of a 2.0 A structure of alpha1-antitrypsin reveals targets for rational drug design to prevent conformational disease. Protein Sci (2000) 1.58
Pathogenesis of periodontitis: a major arginine-specific cysteine proteinase from Porphyromonas gingivalis induces vascular permeability enhancement through activation of the kallikrein/kinin pathway. J Clin Invest (1994) 1.56
Salpingectomy improves the pregnancy rate in in-vitro fertilization patients with hydrosalpinx. Hum Reprod (1996) 1.56
De novo deletion of Xp22.2-pter in a female with linear skin lesions of the face and neck, microphthalmia, and anterior chamber eye anomalies. J Med Genet (1990) 1.55
Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma. Blood (2001) 1.54
Inactive conformation of the serpin alpha(1)-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease. Proc Natl Acad Sci U S A (2000) 1.54
Percutaneous liver biopsy and chronic liver disease in haemophiliacs. Lancet (1978) 1.53
Non-invasive detection of hypoglycaemia using a novel, fully biocompatible and patient friendly alarm system. BMJ (2001) 1.53
A circulating variant of human proalbumin. Nature (1978) 1.52
Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Cancer Epidemiol Biomarkers Prev (1996) 1.52